Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

PCTs must find £100m for drug overspends

Primary care trusts will have to find £100 million from their contingency funds to cover pre- scribing overspends this year.

The scale of the predicted overspend was revealed by the Prescription Pricing Authority in its November prescribing monitoring document.

Dr James Kennedy, RCGP prescribing spokesman, said inflation, national service frameworks and drugs approved by the National Institute for Clinical Excellence had pushed up drug spend.

'Drug inflation has been 8 per cent on average and 12-13 per cent in isolated cases, but that is different to an overspend and a good manager will factor that in,' he added.

He said the quality framework would also impact on prescribing budgets.

The Department of Health said although the forecast was bigger than PCTs' budgets, there would be no overspend. PCTs would use their contingency funds to cover the difference, a spokesman added.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say